- China
- /
- Healthcare Services
- /
- SZSE:300143
INKON Life Technology Co., Ltd.'s (SZSE:300143) stock price dropped 6.4% last week; retail investors would not be happy
Key Insights
- The considerable ownership by retail investors in INKON Life Technology indicates that they collectively have a greater say in management and business strategy
- The top 8 shareholders own 50% of the company
- Past performance of a company along with ownership data serve to give a strong idea about prospects for a business
A look at the shareholders of INKON Life Technology Co., Ltd. (SZSE:300143) can tell us which group is most powerful. And the group that holds the biggest piece of the pie are retail investors with 48% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.
As a result, retail investors as a group endured the highest losses last week after market cap fell by CN¥386m.
In the chart below, we zoom in on the different ownership groups of INKON Life Technology.
See our latest analysis for INKON Life Technology
What Does The Institutional Ownership Tell Us About INKON Life Technology?
Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.
INKON Life Technology already has institutions on the share registry. Indeed, they own a respectable stake in the company. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at INKON Life Technology's earnings history below. Of course, the future is what really matters.
INKON Life Technology is not owned by hedge funds. Qingdao Yingkang Medical Investment Co., Ltd. is currently the largest shareholder, with 42% of shares outstanding. With 2.6% and 1.8% of the shares outstanding respectively, Yunshou Ye and Qingdao Haichuangzhi Management Consulting Enterprise (Limited Partnership) are the second and third largest shareholders.
We did some more digging and found that 8 of the top shareholders account for roughly 50% of the register, implying that along with larger shareholders, there are a few smaller shareholders, thereby balancing out each others interests somewhat.
Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There is a little analyst coverage of the stock, but not much. So there is room for it to gain more coverage.
Insider Ownership Of INKON Life Technology
While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.
Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.
We can report that insiders do own shares in INKON Life Technology Co., Ltd.. As individuals, the insiders collectively own CN¥186m worth of the CN¥5.7b company. It is good to see some investment by insiders, but it might be worth checking if those insiders have been buying.
General Public Ownership
With a 48% ownership, the general public, mostly comprising of individual investors, have some degree of sway over INKON Life Technology. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.
Private Company Ownership
It seems that Private Companies own 43%, of the INKON Life Technology stock. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.
Next Steps:
While it is well worth considering the different groups that own a company, there are other factors that are even more important. For example, we've discovered 1 warning sign for INKON Life Technology that you should be aware of before investing here.
If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SZSE:300143
INKON Life Technology
Focuses on building an ecological platform for chain of pre-diagnosis/treatment/health providing medical services for tumors in China and internationally.
Excellent balance sheet with reasonable growth potential.